These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1200 related items for PubMed ID: 28650134

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
    Tian Z, Yu T, Wei H, Ning N.
    J Clin Lab Anal; 2020 Feb; 34(2):e23071. PubMed ID: 31693242
    [Abstract] [Full Text] [Related]

  • 26. Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents.
    Degasperi E, Perbellini R, D'Ambrosio R, Uceda Renteria SC, Ceriotti F, Perego A, Orsini C, Borghi M, Iavarone M, Bruccoleri M, Rimondi A, De Silvestri A, Sangiovanni A, Lampertico P.
    Aliment Pharmacol Ther; 2022 Feb; 55(3):350-359. PubMed ID: 34738664
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients.
    Yu R, Xiang X, Tan Z, Zhou Y, Wang H, Deng G.
    Sci Rep; 2016 Oct 12; 6():35050. PubMed ID: 27731353
    [Abstract] [Full Text] [Related]

  • 28. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
    Viggiani V, Palombi S, Gennarini G, D'Ettorre G, De Vito C, Angeloni A, Frati L, Anastasi E.
    Scand J Gastroenterol; 2016 Oct 12; 51(10):1257-62. PubMed ID: 27227515
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
    Xu F, Zhang L, He W, Song D, Ji X, Shao J.
    Dis Markers; 2021 Oct 12; 2021():8868370. PubMed ID: 33628341
    [Abstract] [Full Text] [Related]

  • 35. Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP.
    Baek YH, Lee JH, Jang JS, Lee SW, Han JY, Jeong JS, Choi JC, Kim HY, Han SY.
    Hepatogastroenterology; 2009 Oct 12; 56(91-92):763-7. PubMed ID: 19621698
    [Abstract] [Full Text] [Related]

  • 36. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis.
    Guan MC, Ouyang W, Liu SY, Sun LY, Chen WY, Tong XM, Zhu H, Yang T.
    Hepatobiliary Pancreat Dis Int; 2022 Dec 12; 21(6):559-568. PubMed ID: 35643910
    [Abstract] [Full Text] [Related]

  • 37. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
    Jang ES, Jeong SH, Kim JW, Choi YS, Leissner P, Brechot C.
    PLoS One; 2016 Dec 12; 11(3):e0151069. PubMed ID: 26986465
    [Abstract] [Full Text] [Related]

  • 38. [The value of serum abnormal prothrombin in clinical application of hepatocellular carcinoma].
    Zhang JW, Guan LY, E CY, Yang JH, Xuan W, Meng ZH, Li W.
    Zhonghua Wai Ke Za Zhi; 2020 Oct 01; 58(10):776-781. PubMed ID: 32993265
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.